106 related articles for article (PubMed ID: 10471409)
1. Phosphorylation and proteasome-dependent degradation of Bcl-2 in mitotic-arrested cells after microtubule damage.
Chadebech P; Brichese L; Baldin V; Vidal S; Valette A
Biochem Biophys Res Commun; 1999 Sep; 262(3):823-7. PubMed ID: 10471409
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.
Zhang XM; Lin H; Chen C; Chen BD
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 phosphorylation and proteasome-dependent degradation induced by paclitaxel treatment: consequences on sensitivity of isolated mitochondria to Bid.
Brichese L; Barboule N; Heliez C; Valette A
Exp Cell Res; 2002 Aug; 278(1):101-11. PubMed ID: 12126962
[TBL] [Abstract][Full Text] [Related]
4. Heat-shock protein 70 antisense oligomers enhance proteasome inhibitor-induced apoptosis.
Robertson JD; Datta K; Biswal SS; Kehrer JP
Biochem J; 1999 Dec; 344 Pt 2(Pt 2):477-85. PubMed ID: 10567231
[TBL] [Abstract][Full Text] [Related]
5. Influence of p53 and p21Waf1 expression on G2/M phase arrest of colorectal carcinoma HCT116 cells to proteasome inhibitors.
Kim OH; Lim JH; Woo KJ; Kim YH; Jin IN; Han ST; Park JW; Kwon TK
Int J Oncol; 2004 Apr; 24(4):935-41. PubMed ID: 15010833
[TBL] [Abstract][Full Text] [Related]
6. Proteasomes modulate balance among proapoptotic and antiapoptotic Bcl-2 family members and compromise functioning of the electron transport chain in leukemic cells.
Marshansky V; Wang X; Bertrand R; Luo H; Duguid W; Chinnadurai G; Kanaan N; Vu MD; Wu J
J Immunol; 2001 Mar; 166(5):3130-42. PubMed ID: 11207265
[TBL] [Abstract][Full Text] [Related]
7. Potent antitumor agent proteasome inhibitors: a novel trigger for Bcl2 phosphorylation to induce apoptosis.
You SA; Basu A; Haldar S
Int J Oncol; 1999 Oct; 15(4):625-8. PubMed ID: 10493941
[TBL] [Abstract][Full Text] [Related]
8. Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts.
An B; Goldfarb RH; Siman R; Dou QP
Cell Death Differ; 1998 Dec; 5(12):1062-75. PubMed ID: 9894613
[TBL] [Abstract][Full Text] [Related]
9. PS-341, a novel proteasome inhibitor, induces Bcl-2 phosphorylation and cleavage in association with G2-M phase arrest and apoptosis.
Ling YH; Liebes L; Ng B; Buckley M; Elliott PJ; Adams J; Jiang JD; Muggia FM; Perez-Soler R
Mol Cancer Ther; 2002 Aug; 1(10):841-9. PubMed ID: 12492117
[TBL] [Abstract][Full Text] [Related]
10. Proteasome inhibitors induce p53/p21-independent apoptosis in human glioma cells.
Wagenknecht B; Hermisson M; Eitel K; Weller M
Cell Physiol Biochem; 1999; 9(3):117-25. PubMed ID: 10494025
[TBL] [Abstract][Full Text] [Related]
11. p27Kip1 accumulation by inhibition of proteasome function induces apoptosis in oral squamous cell carcinoma cells.
Kudo Y; Takata T; Ogawa I; Kaneda T; Sato S; Takekoshi T; Zhao M; Miyauchi M; Nikai H
Clin Cancer Res; 2000 Mar; 6(3):916-23. PubMed ID: 10741716
[TBL] [Abstract][Full Text] [Related]
12. mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway.
Chang YC; Lee YS; Tejima T; Tanaka K; Omura S; Heintz NH; Mitsui Y; Magae J
Cell Growth Differ; 1998 Jan; 9(1):79-84. PubMed ID: 9438391
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis in human osteosarcoma Saos-2 cells by the proteasome inhibitor MG132 and the protective effect of pRb.
Lauricella M; D'Anneo A; Giuliano M; Calvaruso G; Emanuele S; Vento R; Tesoriere G
Cell Death Differ; 2003 Aug; 10(8):930-2. PubMed ID: 12868001
[No Abstract] [Full Text] [Related]
14. Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation.
Nijhawan D; Fang M; Traer E; Zhong Q; Gao W; Du F; Wang X
Genes Dev; 2003 Jun; 17(12):1475-86. PubMed ID: 12783855
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin/proteasome-dependent degradation of D-type cyclins is linked to tumor necrosis factor-induced cell cycle arrest.
Hu X; Bryington M; Fisher AB; Liang X; Zhang X; Cui D; Datta I; Zuckerman KS
J Biol Chem; 2002 May; 277(19):16528-37. PubMed ID: 11864973
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis in caspase-inhibited neurons.
Volbracht C; Leist M; Kolb SA; Nicotera P
Mol Med; 2001 Jan; 7(1):36-48. PubMed ID: 11474126
[TBL] [Abstract][Full Text] [Related]
17. Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway.
Dimmeler S; Breitschopf K; Haendeler J; Zeiher AM
J Exp Med; 1999 Jun; 189(11):1815-22. PubMed ID: 10359585
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 activates the transcription factor NFkappaB through the degradation of the cytoplasmic inhibitor IkappaBalpha.
de Moissac D; Mustapha S; Greenberg AH; Kirshenbaum LA
J Biol Chem; 1998 Sep; 273(37):23946-51. PubMed ID: 9727009
[TBL] [Abstract][Full Text] [Related]
19. Regulation of synovial cell apoptosis by proteasome inhibitor.
Kawakami A; Nakashima T; Sakai H; Hida A; Urayama S; Yamasaki S; Nakamura H; Ida H; Ichinose Y; Aoyagi T; Furuichi I; Nakashima M; Migita K; Kawabe Y; Eguchi K
Arthritis Rheum; 1999 Nov; 42(11):2440-8. PubMed ID: 10555040
[TBL] [Abstract][Full Text] [Related]
20. BCL6 overexpression prevents increase in reactive oxygen species and inhibits apoptosis induced by chemotherapeutic reagents in B-cell lymphoma cells.
Kurosu T; Fukuda T; Miki T; Miura O
Oncogene; 2003 Jul; 22(29):4459-68. PubMed ID: 12881702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
